Paula Soteropoulos

DNTH

Paula Soteropoulos serves as director at Dianthus Therapeutics, Inc. (DNTH). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$2.25M

Net Position

Net Seller

$2.25M

Companies Traded

DNTH

Active Period

Mar 2026 – May 2026

3 total trades

Most Recent

Sell DNTH

May 11, 2026 · $51.2K

Paula Soteropoulos's Insider Trading at Dianthus Therapeutics, Inc. (DNTH)

Buys

0 · $0.00

Sells

3 · $2.25M

Total Shares Bought

Total Shares Sold

28,792

DNTH Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
May 11, 2026	Sell	599	$85.47	$51.2K
Apr 1, 2026	Sell	599	$80.11	$48.0K
Mar 26, 2026	Sell	27,594	$78.05	$2.15M

Related Insiders

Ryan Savitz

officer: EVP, CFO & CBO

DNTHSell · Jul 13, 2026

Adam M Veness

officer: SVP, General Counsel and Sec.

DNTHSell · Jun 18, 2026

Simrat Randhawa

officer: EVP, Head of R&D

DNTHSell · Jun 2, 2026

CARR EDWARD

officer: CHIEF ACCOUNTING OFFICER

DNTHSell · Mar 13, 2026

Marino Garcia

director, officer: CEO AND PRESIDENT

DNTHSell · Mar 13, 2026

Explore More Insider Trading Data

DNTH Insider Trading Activity

View all insider trades at Dianthus Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity